$AEZS +200% today.

$AEZS is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Company’s lead product, macimorelin, is the first and only U.S. FDA and European Commission approved oral tests indicated for the diagnosis of adult growth hormone deficiency (AGHD).

They make a big jump today on a 217M shares exchanged when the average of the last month is more around the 20 M per day approximately. The point who is interesting its then there is no specific news who are come from the company. Perhaps another move created by retail investors as we see there is few days.

Here is the link of the news section of the company.

Here is the graph of the day.

Here is the 30 day overview.